Nanotechnology Now - Press Release: Former Rice University President Malcolm Gillis Joins nanoTox Board

Home > Press > Former Rice University President Malcolm Gillis Joins nanoTox Board

Abstract:
nanoTox, the only company to provide complete risk assessment exclusively for nanoparticles, announced today that Dr. Malcolm Gillis has joined the board of directors for its parent company, Nano Risk Assessment. Dr. Gillis was president of Rice University for more than a decade following a long, distinguished academic career.

Former Rice University President Malcolm Gillis Joins nanoTox Board

AUSTIN, TX | Posted on February 18th, 2009

"We are delighted with the addition of Dr. Gillis to our board," stated Harry Bushong, president of nanoTox. "He is well respected in both academia and the science community, and his leadership and experience will be invaluable as we work with nanoscience companies to ensure the safety of their products and processes."

Dr. Gillis was Rice University president from 1993 to 2004, and he remains a renowned leader in the field of nanotechnology, having been instrumental in the establishment of the Rice's Richard E. Smalley Institute for Nanoscale Science and Technology and the Rice Alliance. Prior to coming to Rice, Gillis was Dean of the Faculty of Arts and Sciences and Dean of the Graduate School for Duke University. He also has been a frequent Consultant to the World Bank, the U.S. Treasury Department, Oak Ridge National Laboratory, the Canadian Ministry of Finance and the Ford Foundation. Dr. Gillis is vice chair of the Cancer Prevention and Research Institute of Texas, and he serves on the board of directors for several public companies. From 1998 to 2004, he served on the board of the Federal Reserve Bank of Dallas and has served on the board on sustainable development for the National Academy of Sciences. He was on the advisory boards of the Oak Ridge National Laboratory, the International Center for Economic Growth and KPMG Peat Marwich Policy Economics Group. In addition, he served on the board of trustees for the Foundation for Hospital Art, the Francisco Marroquin Foundation, Friends of Education in Chile, the Institute of International Education and the Houston Advanced Research Center.

Dr. Gillis has received many honors in academia, including being recognized as a Distinguished Fulbright Professor at the Catholic University of Chile in 1989. He was awarded the NATA public service medal in 2004. A widely published economist, Dr. Gillis has authored or co-authored 10 books and dozens of articles for publications throughout the world.

A native of Marriana, Fla., Dr. Gillis earned his B.A. and M.A. from the University of Florida and his Ph. D. from the University Of Illinois. He holds an honorary Doctor of Laws from Rocky Mountain College

####

About nanoTox Inc.
Located in Austin, Texas, nanoTox is the only company to provide complete assessment exclusively for nanoparticles. nanoTox determines the toxicity of its clients’ nanoproducts and offers strategies for managing, reducing or eliminating risk to meet state and federal safety guidelines and shorten time to market. Because nanoTox uses methodologies that are performed under recognized international data quality standards (GLP, ISO, etc.) in its laboratories, the results and associated assessments are suitable for use to support regulatory decisions, product registrations, litigation and for acceptance by the insurance industry.

nanoTox ensures complete client confidentiality for all of its clients, which include companies or entities that require government approval to market their nanoproducts, venture capital firms that invest in nanoproduct companies, law firms engaged by such companies and insurance companies considering insuring such companies from liability.

nanoTox is headquartered in Austin, Texas, with offices in Maastricht, Netherlands.

For more information, please click here

Contacts:
Laura P. Wright
CameronWeeks Public Relations
Tel. 512.461.5777

www.cameronweeks.com

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: